Alpha 2.0
Login Register
» Authors » Anna Peguero

Anna Peguero

Explore the profile of Anna Peguero including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 151
Followers 0
Related Specialties
Gynecology & Obstetrics
General Medicine
Physiology
Top 10 Co-Authors
Francesc Figueras
Edurne Mazarico
Eduard Gratacos
Eva Meler
Fatima Crispi
Francesca Crovetto
Stefania Triunfo
Alba Gonzalez
Javier Caradeux
Jon Schoorlemmer
Published In
Am J Obstet Gynecol
Fetal Diagn Ther
Placenta
BMJ Open
Pregnancy Hypertens
Affiliations
Soon will be listed here.
Recent Articles
1.
TREATMENT OF EARLY-ONSET FETAL GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN DOES NOT PROLONG GESTATION: A RANDOMIZED CLINICAL TRIAL
Gonzalez A, Peguero A, Meler E, Camprubi-Camprubi M, Rovira C, Gomez-Roig M, et al.
Am J Obstet Gynecol . 2024 Nov; PMID: 39521297
Background: Although there is a biological basis for it, there is scarce evidence on the effect of heparin in ameliorating placental insufficiency and maximizing gestational age at delivery among fetal...
2.
Cook's balloon versus dinoprostone for Labour induction of term pregnancies with fetal GROWth restriction: study protocol for a randomised controlled trial in tertiary maternity hospitals in Spain (COLIGROW study)
Herraiz I, Meler E, Mazarico E, Bonacina E, Blanco J, Villalain C, et al.
BMJ Open . 2024 Sep; 14(9):e089628. PMID: 39349375
Introduction: Fetal growth restriction (FGR) affects about 3%-5% of term pregnancies. If prenatally detected and anterograde umbilical artery flow is preserved (stage I), it is recommended to deliver at term...
3.
Prediction of adverse neonatal outcome at admission for early-onset preeclampsia with severe features
Peguero A, Fernandez-Blanco L, Mazarico E, Benitez L, Gonzalez A, Boada D, et al.
Pregnancy Hypertens . 2023 Apr; 32:64-69. PMID: 37116297
Background: Preeclampsia remains the leading cause of maternal morbidity and mortality. Consequently, research has focused on validating tools to predict maternal outcomes regarding clinical and biochemical features from the maternal...
4.
Third-trimester uterine artery Doppler for prediction of adverse outcome in late small-and adequate for-gestational-age fetuses
Mula C, Hidalgo J, Peguero A, Mazarico E, Martinez J, Figueras F, et al.
Minerva Obstet Gynecol . 2023 Mar; 75(5):440-448. PMID: 36943257
Fetal growth restriction includes all those fetuses that do not reach their own growth potential due to placental insufficiency and therefore at higher risk of adverse perinatal outcomes. Identification and...
5.
Death and severe morbidity in isolated periviable small-for-gestational-age fetuses
Meler E, Mazarico E, Peguero A, Gonzalez A, Martinez J, Boada D, et al.
BJOG . 2022 Apr; 130(5):485-493. PMID: 35437890
Objective: This study aims to predict perinatal death or severe sequelae in isolated small-for-gestational-age fetuses, diagnosed at a periviable gestational age, based on ultrasound and Doppler parameters at diagnosis. Design:...
6.
Placental growth factor testing in the management of late preterm preeclampsia without severe features: a multicenter, randomized, controlled trial
Peguero A, Herraiz I, Perales A, Melchor J, Melchor I, Marcos B, et al.
Am J Obstet Gynecol . 2021 Apr; 225(3):308.e1-308.e14. PMID: 33823150
Background: In women with late preterm preeclampsia, the optimal time for delivery remains a controversial topic, because of the fine balance between the maternal benefits from early delivery and the...
7.
Cytogenetic Investigation in 136 Consecutive Stillbirths: Does the Tissue Type Affect the Success Rate of Chromosomal Microarray Analysis and Karyotype?
Marques B, Benitez L, Peguero A, Madrigal I, Gomez O, Figueras F, et al.
Fetal Diagn Ther . 2020 Jan; 47(4):315-320. PMID: 31955157
Background: Chromosomal anomalies are a recognized cause of stillbirth, accounting for 6-17% of the cases. As a diagnostic laboratory method in this setting, conventional karyotyping has two main drawbacks: the...
8.
Association of plasma lactate concentration at admission of severe preeclampsia to maternal complications
Peguero A, Parra R, Carrillo S, Rojas-Suarez J, Figueras F
Pregnancy Hypertens . 2019 Sep; 17:89-93. PMID: 31487663
Objective: To evaluate in women with severe preeclampsia the association of lactate concentration at admission with maternal complications. Methods: A prospective cohort was created of women with severe preeclampsia consecutively...
9.
Diagnostic performance of third-trimester ultrasound for the prediction of late-onset fetal growth restriction: a systematic review and meta-analysis
Caradeux J, Martinez-Portilla R, Peguero A, Sotiriadis A, Figueras F
Am J Obstet Gynecol . 2019 Jan; 220(5):449-459.e19. PMID: 30633918
Objective: The objective of the study was to establish the diagnostic performance of ultrasound screening for predicting late smallness for gestational age and/or fetal growth restriction. Data Sources: A systematic...
10.
Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP)
Mazarico E, Peguero A, Camprubi M, Rovira C, Gomez Roig M, Oros D, et al.
BMJ Open . 2018 Oct; 8(10):e020501. PMID: 30355790
Introduction: The incidence of intrauterine growth restriction (IUGR) is estimated at about 3% of pregnancies, and it is associated with 30% of all perinatal mortality and severe morbidity with adverse...